AAV Services for Gene Therapy - Virtual Event

Ginkgo's AAV Services for Gene Therapy: Integrated solutions across capsid, payload, and cell line engineering for manufacturing.
The STRIVE platform was built to address three major challenges: pre-existing immunity, tissue tropism, and manufacturability. With the recent acquisition of StrideBio, Ginkgo can now bring the STRIVE capsid engineering platform to our customers supported by the power of our industry-leading synthetic biology Foundry.
The existing STRIVE capsids are backed by a wealth of performance data, including studies in large animal models. A range of capsids are ready to go for partners to match to their desired indication or application.
Additional capsids in earlier stages of development are differentiated with in vivo or ex vivo data to show enhanced tissue tropism or potency relative to their parental backgrounds. Consider capsids specialized for the CNS, heart, muscle, liver, or even ex vivo targets such as T-cells.
In Ginkgo's Foundry, these proprietary capsid technologies are only the beginning. Our extensive capacity for high-throughput engineering of proteins and regulatory elements can enable the ambitions of our partners across the gene therapy space.
Learn more at
www.ginkgobiow...

[@redpanda7975]

Bunch of smart as hell people working here